Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
- Status
- RECRUITING
- Phase
- N/A
Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Ibrutinib Adapted to Response in Patients With CLL
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Status
- RECRUITING
- Phase
- N/A
Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Zanubrutinib Followed Zanubrutinib Plus FCR / BR in Newly Diagnosed Symptomatic CLL/SLL
- Status
- UNKNOWN
- Phase
- PHASE2
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
MargheRITA (Remote Intelligence for Therapeutic Adherence)
- Status
- COMPLETED
- Phase
- NA
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- RECRUITING
- Phase
- PHASE3
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- N/A
Financial Difficulty in Patients With Blood Cancer
- Status
- COMPLETED
- Phase
- N/A
A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL
- Status
- RECRUITING
- Phase
- PHASE3
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
- Status
- RECRUITING
- Phase
- PHASE2